FLT3 (FMS-like tyrosine kinase 3) is a cytokine receptor which belongs to the receptor tyrosine kinase class III and plays a role in cell survival, proliferation, and differentiation.
- Cat.No. Product Name Information
- GC11205 5'-Fluoroindirubinoxime FMS-like receptor tyrosine kinase-3 (FLT3) inhibitor
A potent and selective PDGFR family inhibitor
- GC16604 Altiratinib c-MET/TIE-2/VEGFR inhibitor
- GC14974 AMG 925 FLT3/CDK4 inhibitor,potent and selective
- GC35315 AMG 925 HCl
Amuvatinib (MP-470, HPK 56)
Tyrosine kinase inhibitor
- GC33362 Amuvatinib hydrochloride (MP470 hydrochloride)
- GC10914 AST 487 RET kinase inhibitor
- GC10638 AT9283 Aurora kinase/JAK inhibitor
- GC17959 AZD2932 inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit
- GC19080 BPR1J-097 BPR1J-097 is a novel potent FLT3 inhibitor with an IC50 of 11 nM.
- GC35544 BPR1J-097 Hydrochloride
- GC15779 Cabozantinib (XL184, BMS-907351) VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor
- GC19092 CCT241736 CCT241736 is a potent and orally bioavailable dual FLT3 and Aurora kinase inhibitor, which inhibits Aurora kinases (Aurora-A Kd, 7.5 nM, IC50, 38 nM; Aurora-B Kd, 48 nM), FLT3 kinase (Kd, 6.2 nM), and FLT3 mutants including FLT3-ITD (Kd, 38 nM) and FLT3(D835Y) (Kd, 14 nM).
- GC33064 CG-806
- GC15739 CHIR-124 Chk1 inhibitor,novel and potent
- GC14906 Crenolanib (CP-868596) PDGFR-β inhibitor,potent and selective
- GC38412 Crotonoside
- GC14007 DCC-2036 (Rebastinib) Bcr-Abl inhibitor
- GC13547 Dovitinib (TKI-258, CHIR-258) Multitargeted RTK inhibitor